baber/WOPTO huggingface dataset:
Patent NZ-583876-A (NZ)
Title: Tricyclic amide compound
Inventor: AMANO YOHEI
IPC: A61K31/381
Filed: 2008-08-14
Abstract: A tricyclic amide compound represented by the general formula (I) is disclosed, wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B independently represent -(CH2)2-, -(CH2)3- or -(CH2)4-, X represents -N(R2)-CO-; R2 represents hydrogen atom or a C1-6 alkyl group, -CO-N(R3)-; R3 represents hydrogen atom or a C1-6 alkyl group, -C(R4)=C(R5)-; R4 and R5 independently represent hydrogen atom or a C1-6 alkyl group, or -N(R6)-SO2-; R6 represents hydrogen atom or a C1-6 alkyl group, and Ar represents an aryldiyl group or a heteroaryldiyl group; the aryldiyl group and the heteroaryldiyl group may have a substituent, a salt thereof, or an ester thereof. This tricyclic amide compound has retinoid action and is useful as an active ingredient of pharmaceutical products for treating a disease or condition associated with retinoid action.
Patent NZ-585558-A (NZ)
Title: Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: A61P13/08
Filed: 2008-07-10
Abstract: Crystalline Form IV of doxazosin mesylate, characterized by having an XRD pattern comprising peaks at 7.1, 11.8 and 13.9 deg2theta ± 0.2 deg2theta is disclosed. A therapeutically effective amount of crystalline Form IV of doxazosin mesylate in a medicament is suitable for treating hypertension or benign prostatic hyperplasia.
Patent NZ-587931-A (NZ)
Title: Method of sealing a leak utilising an elastomeric sealing element and a non-Newtonian fluid
Inventor: RYAN NICHOLAS JOHN
IPC: C09K3/12
Filed: 2009-03-12
Abstract: 587931 Disclosed is a method of sealing a leak using a sealing mixture comprising at least one elastomeric sealing element (3) and a non-Newtonian fluid (2). The sealing mixture is introduced into a closed environment (1) such that it is at a positive pressure relative to the adjacent environment (5). Thus, at the locality of the defect (4), there is a pressure differential through which the content of the closed environment (1) can leak into the adjacent environment (5). This pressure differential applies a shear force which acts on the sealing mixture to cause it to flow through the defect (4) causing one or more of the close-by sealing elements (3) to be drawn to the defect (4) so that a number of sealing elements (3) will completely span the leak.
Patent NZ-590233-A (NZ)
Title: Lanosta-8,24-dien-3-ols for treating pain by modulating serine-threonine protein kinases
Inventor: PIANOWSKI LUIZ FRANCISCO
IPC: A61K31/575
Filed: 2008-08-05
Abstract: Use of one or more lanosta-8,24-dien-3-oIs in the manufacture of a medicament suitable for administration to a mammalian subject for the treatment of pain is disclosed, wherein said pain is linked to the disordered activation of serine-threonine protein kinases, wherein said medicament inhibits the increased or reduced activation of serine-threonine protein kinases, or the transcription factors modulated by them; and wherein said lanosta-8,24-dien-3-oIs are selected from euphol, tirucallol and lanosterol, or the isomers, derivatives, solvates or hydrates, or mixture thereof.
Patent NZ-594789-A (NZ)
Title: Activation of an intermediate-networking function of an end-user device based on a user preference
Inventor: RALEIGH GREGORY G
IPC: G06Q10/06
Filed: 2010-01-19
Abstract: A first end-user device comprises an access-network modem configured to assist the first end-user device in communicating with a network element over a wireless access network; a wireless local-area-network modem configured to assist the first end-user device in communicating with one or more other end-user devices over a wireless local-area network; a user interface; and one or more processors configured to: assist in presenting, through the user interface, an option to activate an intermediate-networking function, the intermediate-networking function capable of allowing at least one of the one or more other end-user devices to communicate through the first end-user device with a network system over the wireless access network, obtain a user preference associated with the option to activate the intermediate-networking function, the user preference indicating whether to activate the intermediate-networking function, and send a message to the network element, the message configured to convey the user preference.
Patent NZ-595293-A (NZ)
Title: Substituted spiro-amide compounds for use in the treatment of pain
Inventor: SCHUNK STEFAN
IPC: A61K31/4406
Filed: 2010-03-23
Abstract: Disclosed herein are compounds of the general formula (I), where the variables are define in the specification, for use in the treatment of pain, in particular acute pain, visceral pain, neuropathic pain, chronic pain and or inflammation pain; migraine; diabetes; diseases of the respiratory tract; inflammatory intestinal diseases; neurological diseases; neurodegenerative diseases, fibrotic diseases, inflammations of the skin; rheumatic diseases; septic shock; reperfusion syndrome; obesity and or as an angiogenesis inhibitor. Examples of the compounds disclosed herein are: 2-chloro-N-[(1R)-6-(8-pyridin-4-yl-3,8-diazaspiro[4.5]decane-3-carbonyl)-2,3-dihydro-1H-inden-1-yl]-benzamide; (E)-3-(2-chlorophenyl)-N-[2,2-dimethyl-6-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carbonyl)-1,3-dihydro-inden-1-yl]-acrylamide; N-[2,2-Dimethyl-6-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carbonyl)-1,3-dihydro-inden-1-yl]-2,6-dimethyl-benzamide; and 2-Chloro-N-[6-[8-[(2-dimethylamino-pyrimidin-5-yl)-methyl]-2,8-diazaspiro[4.5]decane-2-carbonyl]-2,3-dihydro-IH-inden-1-yl]-6-fluoro-benzamide.
Patent NZ-596970-A (NZ)
Title: Vessel and method for making the same with rolled lower part and flaps and spout at upper part
Inventor: HERMAN PETER
IPC: B65D1/26
Filed: 2010-06-11
Abstract: A vessel (100) composed of a sheet of flexible material, cut, rolled, and affixed to form a frusto-conically shaped base region (101). The sheet when rolled including an upper region having two opposing flaps (103,113), each flap delineated from a remaining portion of the sheet by a path (118) along which the sheet is scored, so that the flaps, when folded along their respective paths, define a single elevated drinking portion having a spout (104) formed between an extension of the base region and at least one of the two flaps.
Patent NZ-597657-A (NZ)
Title: Use sulphur particles less than 300 microns and sodium lignin sulfonate for treating diseases casused by microbial pathogenic infections
Inventor: WALKER RALPH
IPC: A61K9/14
Filed: 2012-01-18
Abstract: ABSTRACT - 597657 The disclosure relates to a use of a composition comprising as an active ingredient sulphur particles less than 300 microns and sodium lignin sulfonate, in the manufacture of a medicament for treating lung and respiratory disorders, bone, joint and muscle disorders, digestive disorders, diabetes, cancer and/or viral infections, in a patient in need thereof.
Patent NZ-602388-A (NZ)
Title: Valve system
Inventor: TVEITEN MAGNAR
IPC: E21B34/10
Filed: 2011-02-16
Abstract: 602388 Disclosed is a valve system for use in a wellbore. The valve system performs with an artificial lifting system used to assist in forming pressure to extract more hydrocarbons. The valve system comprises a side pocket mandrel. The side pocket mandrel comprises an elongated body section (7) which is provided with a substantially fully open main bore (9) for alignment with well tubing. The side pocket mandrel further comprises a laterally offset side pocket with a bore (10). The main bore (9) and the side pocket bore (10) are separated by an internal wall (11). At least one through opening (12) is provided in the side pocket mandrel which leads into the side pocket bore (10). At least one through opening (13) is provided in the internal wall (11) which leads to the main bore (9). The side pocket bore (10) has at least two valves (100, 101) which are arranged in series to form a double fluid barrier between the main bore (9) and an outside of the pocket mandrel. The two valves (100, 101) are retrievable through at least one installation opening arranged in the internal wall (11) of the side pocket mandrel.
Patent NZ-603417-A (NZ)
Title: Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
Inventor: GLICK GARY D
IPC: A61K31/55
Filed: 2006-11-01
Abstract: Disclosed are substituted-benzodiazepine-2,5-dione derivatives represented by structural formula depicted herein, wherein the variables are as defined in the specification. These compounds are suitable for treating a disease or disorder selected from hyperproliferative disorder, autoimmune disorder, chronic inflammatory condition, or atherosclerosis, including conditions such as graft-versus-host disease, psoriasis, rheumatoid arthritis, cancer, Sjogren’s syndrome, myasthenia gravis, asthma, systemic lupus erythematosus, multiple sclerosis, celiac sprue, idiopathic thrombocytopenia purpura, scleroderma, Crohn’s Disease, inflammatory bowel disease, and ulcerative colitis.
Patent NZ-611525-A (NZ)
Title: Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
Inventor: BACHMANN FELIX
IPC: G01N33/50
Filed: 2012-01-19
Abstract: Disclosed is the use of a glu-tubulin as a biomarker for predicting the response to a compound, wherein the compound is a compound of general formula I, and formula I is as defined in the specification.
Patent NZ-625969-A (NZ)
Title: Discrimination of cheyne-stokes breathing patterns
Inventor: ARMITSTEAD JEFFREY PETER
IPC: A61M16/00
Filed: 2013-01-25
Abstract: Disclosed is a method of a processor for detecting a presence of Cheyne-Stokes respiration from a respiration signal. The method comprises accessing data representative of the respiration signal and assessing the accessed data to detect apnea and/or hypopnea events. Evaluating respiratory data directly following apnea or hypopnea events to estimate a shape feature representing change in the respiratory data. Generating a cycle length histogram based on the events and detecting an incident of Cheyne-Stokes respiration based on the cycle length histogram and the estimated shape feature. The cycle length histogram and the shape feature are generated independently from each other. An incident of Cheyne-Stokes respiration is detected based on the cycle length histogram and the estimated shape feature.
Patent NZ-701375-A (NZ)
Title: A trailer coupling
Inventor: TAYLOR JAMES LESLIE
IPC: B60D1/58
Filed: 2013-07-26
Abstract: A multi fit trailer coupling which is dimensioned for two sizes of tow ball and which is adapted to automatically fit either size of tow ball to avoid inadvertent use with an incorrect size of tow ball which in the past could result in a towing failure with an inherent risk to persons and property. The coupling includes a body adapted at one end for attachment to a draw bar of a trailing vehicle and having at its other end socket means for receiving and locating therein a tow ball. A socket means partly formed by a cavity or passage in which a plunger is mounted. The plunger is spring loaded to press against the surface of the tow ball, the plunger having on its lower face a part spherical face the curve of which match a desired diameter tow ball. The socket means opposite the lower face of the plunger has on its inner face a part spherical face the curves of which match that of the desired tow ball so that, in use, the tow ball is engaged between the respective part spherical surfaces. The plunger is mounted to reciprocate up and down the passage under either the bias of the spring or by movement of a handle formed at the upper end of the plunger. The position of the plunger in the cavity is locked by a spring loaded catch which locks the plunger in position. The socket means can have in association therewith a recess in which is inserted a damper formed from a reaction polymer material. The damper extending into the socket means to contact a tow ball to thereby substantially eliminate rattle therebetween.
Patent NZ-703464-A (NZ)
Title: Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
Inventor: KERAMIDAS PANAGIOTAS
IPC: A61K9/26
Filed: 2007-04-26
Abstract: Disclosed is a controlled-release formulation comprising one or more distinct and discrete units located in physical juxtaposition to enable administration to a patient in need of treatment in a single dose, characterised in that the or each unit comprise(s): (i) a unit dose of an active pharmaceutical ingredient or pharmaceutically acceptable salt thereof; (ii) one or more extended-release agent(s); and, optionally, (iii) one or more pharmaceutically acceptable excipients, wherein the sum of the unit dose(s) constitutes a pharmaceutically effective amount of the active pharmaceutical ingredient.
Patent NZ-706152-A (NZ)
Title: Ectoparasiticidal methods and formulations
Inventor: WINKLE JOSEPH RAYMOND
IPC: A01N25/02
Filed: 2013-11-07
Abstract: Provided are methods and formulations for topically controlling ectoparasite infestations in animals using spinetoram, or a pharmaceutically acceptable salt thereof in a formulation that further comprises benzyl alcohol and propylene carbonate.
Patent NZ-706289-A (NZ)
Title: Pap system
Inventor: VINOKUR ROMAN
IPC: A61M16/06
Filed: 2010-08-27
Abstract: A lightweight housing for a positive airway pressure system blower attachable to a user has a plastic housing and a stator and motor within the housing. An EMF shield is provided so that in use it lies between the motor and user.
Patent NZ-710558-A (NZ)
Title: Energy absorber assembly and components thereof
Inventor: CASEBOLT SCOTT
IPC: A62B35/00
Filed: 2014-01-02
Abstract: Energy absorber assemblies used in conjunction with fall arrest equipment may interfere with the operation of such equipment, especially if they are relatively large and/or are in positions where they could easily become tangled with lifelines, safety harnesses and the like. Disclosed is an energy absorber assembly that may be relatively compact and connect securely to a safety harness having a dorsal D-ring and a lifeline. Such an energy absorber assembly comprises a connector, a bracket assembly, a fastener, and an energy absorber. The connector is configured and arranged to operatively connect to the safety harness proximate the dorsal D-ring. The bracket assembly includes a base and a swivel connector, the swivel connector being movable relative to the base and configured and arranged to operatively connect to the lifeline. The fastener operatively connects the bracket assembly and the connector, and the fastener releases the bracket assembly from the connector when subjected to a predetermined load. The energy absorber operatively connects the bracket assembly and the connector, and the energy absorber includes a first portion and a second portion that separate to absorb shock after the bracket assembly is released from the connector.
Patent NZ-723166-A (NZ)
Title: Apparatus and process for packaging a product.
Inventor: CAPITANI STEFANO
IPC: B65B7/16
Filed: 2015-02-10
Abstract: An process and apparatus for packaging a product arranged on a support is disclosed. The apparatus (see also Figures 2 to 6 and 6C to 11) comprises a packaging assembly (8) configured for tightly fixing one or more film sheets (18) to one or more supports (4). The packaging assembly includes a lower tool (22) comprising at least an inner wall (23)n defining a prefixed number of seats (23b) for receiving the supports (4), and an upper tool (21) facing the lower tool (22) and comprising a film holding plate (36) configured for holding the one or more film sheets, the film holding plate (36) having a respective active surface (37) configured for receiving the one or more film sheets (18), at least the upper and lower tools (21; 22) cooperating to define a packaging chamber (24). The packaging assembly (8) is configured to operate at least in a first operating condition, where said packaging chamber (24) is open to receive the one or more film sheets (18), and in a second operating condition, where said packaging chamber (24) is hermetically closed. The film holding plate (36) has a lateral surface extending substantially perpendicular to a plane defined by the active surface (37), the film holding plate (36) comprising a plurality of ejectors (36c) arranged in the lateral surface, each of the plurality of ejectors (36c) being configured for ejecting a stream of gas (31b) in a direction substantially parallel to said plane and substantially away from a center of the active surface (37). The process includes the step of activating ejection of a plurality of streams of gas around a perimeter of the film holder and over a peripheral portion of cut film sheets in a direction substantially parallel to a plane defined by the cut film sheet and away from a center of the cut film sheet, in order to position and/ or maintain the peripheral portion substantially within the plane of the cut film sheet. Provision of ejectors 31b is directed at prior art problems of configuring and positioning a film sheet and temperature control problems with undesired shrinking of the film sheet material.
Patent NZ-728223-A (NZ)
Title: Process and apparatus for making coffee having less bitterness
Inventor: FEARN MICHAEL
IPC: A47J31/18
Filed: 2015-08-02
Abstract: Provided is a coffee extraction process and apparatus. The process comprises: a) providing a brewing vessel comprising an intimate mixture of coffee grounds and an aqueous medium; b) reducing the pressure to be between about 23.7 kPa and 50.8 kPa; c) brewing the coffee at reflux whilst maintaining the pressure; and d) increasing the pressure in the brewing vessel to atmospheric pressure; wherein step c) is sustained for a period of time between 1 and 5 minutes; and wherein commencement of the period of time is determined from the point at which the aqueous medium reaches its water reflux temperature. The process selectively consumes many of the reactive compounds that are responsible for some of the bitterness, whilst simultaneously avoiding high temperatures which can thermally decompose some of the more desirable complex organic compounds. During the intensive reduced pressure reflux extraction, several of the compounds which can give coffee its bitter and astringent taste are subject to reaction, such as by way of condensation, polymerisation and/or thermally catalysed reduced pressure promoted decarboxylation. The reaction products present at the end of the brewing step appear to have more tolerable flavours (e.g. esters and polyols rather than acids and aldehydes), and/or have reduced solubility and are therefore removed with the grinds during a subsequent separation. Coffee obtained by the inventive process can be characterised by its unique chemical composition and is generally denoted as caffè depurato. It can also be distinguished from caffè espresso, French Press and other prior art coffee extracts by its rich and extra smooth flavour. Traditionally espresso is the base for drinks such as a caffè latte, cappuccino, caffè macchiato, caffè mocha, flat white, or caffè Americano. The specification further demonstrates that caffè depurato can now be substituted as the base for making these same styles of beverages.
Patent NZ-749272-A (NZ)
Title: Phospholipid ether analogs for the identification and isolation of circulating tumor cells
Inventor: WEICHERT JAMEY
IPC: G01N33/574
Filed: 2017-06-14
Abstract: The present invention is directed to a method of identifying, isolating, and enabling downstream analysis of circulating tumor cells comprising contacting a blood or blood serum sample of a subject with a composition comprising a phospholipid ether analog bound to a luminescent molecule or a magnetic bead and subjecting the blood or blood serum sample of the subject to fluorescent microscopy, flow cytometry or magnetic isolation.
Patent NZ-752615-A (NZ)
Title: Method and analysis system for testing a sample
Inventor: WEBER CHRISTOPH
IPC: G01N35/00
Filed: 2017-10-05
Abstract: A method and an analysis system for testing a particular biological sample are proposed, nucleic-acid products being hybridised to capture molecules of a sensor apparatus at different temperatures. In particular, there is provided a method for testing a particular biological sample (P), wherein amplification products (V) are formed from analytes of the sample (P), wherein the amplification products (V) are bonded to corresponding capture molecules of a sensor apparatus comprising a sensor compartment and the bonded amplification products are detected or identified in a detection process, characterised in that a first group of amplification products (V1) of at least one first analyte and a second group of amplification products (V2) of at least one second analyte are bonded in the sensor compartment to the corresponding capture molecules at different hybridisation temperatures (TH), and that the first group and the second group are fed to the sensor compartment and bonded to the corresponding capture molecules in succession.
Patent NZ-757752-A (NZ)
Title: Inhaler with synthetic jetting
Inventor: LEONARD ROBERT
IPC: A61M15/00
Filed: 2018-05-22
Abstract: A dry powder inhaler consisting of a reusable base unit and a disposable drug package is disclosed. The reusable portion may house a transducer, a controller, battery and user interface. The disposable portion may house a dose pellet in a sealed dose chamber that includes an integrated mouthpiece. A user may couple the disposable portion to the reusable portion of the inhaler. The inhaler may sense the user’s breathe and synchronize delivery of the pharmaceutical or drug to the user.
Patent NZ-768989-A (NZ)
Title: An aerosol provision device configured to receive a plurality of aerosolisable materials.
Inventor: LEAH THOMAS DAVID
IPC: A24F40/65
Filed: 2019-05-08
Abstract: An aerosol provision device is configured to receive a plurality of aerosolisable materials. The aerosol provision device is configured to recognise an identity and a position of the aerosolisable materials received in the device and transmit data indicating the identity and the position of the aerosolisable materials received in the device to a separate communication system.
Patent PT-102238-A (PT)
Title: Dissociation of water for energy production consists of controlled heating to yield oxygen and hydrogen for combustion in an irreversible process
IPC: C25B1/04
Filed: 1999-01-08
Abstract: The dissociation of water for energy production comprises heating by resistor (5) of the water entering tank (2) at point (1) and leaving for tank (4) via pipe (3). The resulting steam enters the metal coil in tank (6), with heat dissipated via graphite bars. Application of electricity causes the graphite bars to act as resistors, yielding oxygen and hydrogen from the steam. These are combusted by an electric beam.
Patent PT-107020-A (PT)
Title: Processo para a produção de indigo e seus derivados
Inventor: REBELO SUSANA LUÍSA HENRIQUES
IPC: C07B41/00
Filed: 2013-06-21
Abstract: PRESENTE INVENÇÃO DESCREVE UM NOVO PROCESSO ECOCOMPATÍVEL PARA A SÍNTESE DO CORANTE INDIGO E SEUS DERIVADOS, ATRAVÉS DA REAÇÃO DO INDOLE E/OU SEUS DERIVADOS, NA PRESENÇA DE PERÓXIDO DE HIDROGÉNIO NUM SOLVENTE E UM CATALISADOR. O REFERIDO PROCESSO É BASEADO NA REAÇÃO DE OXIDAÇÃO CATALÍTICA DO INDOLE NUM SOLVENTE NÃO TÓXICO, NÃO NOCIVO E RECICLÁVEL OU BIODEGRADÁVEL. O AGENTE OXIDANTE UTILIZADO É O PERÓXIDO DE HIDROGÉNIO, CONSIDERADO UM OXIDANTE ¿VERDE¿, SENDO O CATALISADOR UMA METALOPORFIRINA. A REAÇÃO CATALÍTICA DECORRE À TEMPERATURA AMBIENTE. NESTE CONTEXTO, O PROCESSO DESCRITO PERMITE UMA REDUÇÃO CONSIDERÁVEL DO IMPACTO AMBIENTAL DA PRODUÇÃO DE INDIGO RELATIVAMENTE AOS PROCESSOS PRESENTEMENTE CONHECIDOS E UTILIZADOS, UMA VEZ QUE DIMINUI A PERIGOSIDADE E QUANTIDADE DOS REAGENTES UTILIZADOS, A ENERGIA DESPENDIDA E OS TEMPOS DE REAÇÃO.